We also observe increased effector differentiation of CXCR5+PD‐1+ CD8 T cells in CLL patients, both directly ex vivo and after stimulation, which could hamper the ability of these cells to induce long‐lasting immune responses. The gene discussed is CXCR5; the disease is B-cell chronic lymphocytic leukemia.